[ȸ»ç¼Ò°³]

±Û·Î¹ú ADC Platform±â¾÷


[¸ðÁýºÎ¹®]

KOSDAQ»óÀå ADC&¹ÙÀÌ¿ÀÇÕ¼ºÀǾàÇ° Á¦¾à»ç ¹ÙÀÌ¿ÀÆÀÀå


[´ã´ç¾÷¹«]

- Ph.D. degree in pharmacology, biology, molecular biology, biochemistry, or related field
- 10+ years (at least 5+ years in Immuno-oncology, cancer biology, or antibody therapeutics) of experience in a drug discovery setting (biotech or large pharma) or relevant industry experience in a biopharmaceutical setting with extensive experience from target validation to IND-enabling studies
- Demonstrated application of expertise to drug discovery in multiple therapeutic areas, including immuno-oncology
- Deep understanding of preclinical PK/PD/efficacy relationships and their translation to the clinic
- Strong leadership, interpersonal and communication skills with an enthusiasm for participating in a fast-paced environment characterized by rigorous science and innovative thinking
- A team player and mentor, who listens effectively and invites response and discussion. A collaborator who communicates in an open, clear, complete, timely and consistent manner


[ÀÚ°Ý ¿ä°Ç]
- Àü°ø : ¾à¸®ÇÐ, »ý¹°ÇÐ, ºÐÀÚ»ý¹°ÇÐ, »ýÈ­ÇÐ ¶Ç´Â °ü·Ã Çаú
- Çз : ¹Ú»çÇÐÀ§ º¸À¯ÀÚ
- 10³â ÀÌ»ó (¸é¿ªÇ×¾ÏÇÐ, ¾Ï»ö¹°ÇÐ ¶Ç´Â Ç×üġ·áÇÐ ºÐ¾ß¿¡¼­ ÃÖ¼Ò 5³â ÀÌ»ó) ¾à¹° ¹ß°ß ȯ°æ
(¹ÙÀÌ¿ÀÅØ ¶Ç´Â ´ëÇü Á¦¾à»ç) ¿¡¼­ÀÇ °æÇè (10³â ÀÌ»ó »ê¾÷ü¿¡¼­ ½Å¾à°³¹ß °æÇè)
- µð½ºÄ¿¹ö¸® ´Ü°èºÎÅÍ IND ±îÁö ±¤¹üÀ§ÇÑ °æÇèÀ» °¡Áø °ü·Ã ¾÷°è °æÇè


£ª±Ù¹«Áö

´ëÀü|´ëÀü


* Á÷±Þ

[ºÎÀå±Þ]


[Á¦Ãâ¼­·ù]

À̷¼­, °æ·Â±â¼ú¼­, ÀÚ±â¼Ò°³¼­

  

[Á¦Ãâó]

´ã´çÀÚ¸í   ÀüÁø »ó¹«ÀÌ»ç

ÀüÈ­¹øÈ£   ***-****-****


www.nterway.com



¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬


¢ß¿£ÅÍ¿þÀÌÆÄÆ®³Ê½º´Â Áֹεî·Ï¹øÈ£ ¼öÁý ±ÝÁö ¹ý·É°ú °øÁ¤È­¿¡ °üÇÑ ¹ý·ü¿¡ ÀÇ°ÅÇÏ¿©, ´ÙÀ½°ú °°Àº Á¤º¸¸¦ ¼öÁýÇÏÁö ¾Ê½À´Ï´Ù. 

1. ±¸Á÷ÀÚ º»ÀÎÀÇ »ý³â¿ùÀÏÀ» Á¦¿ÜÇÑ Áֹεî·Ï¹øÈ£

2. ±¸Á÷ÀÚ º»ÀÎÀÇ ¿ë¸ð,Å°,üÁß µîÀÇ ½ÅüÀû Á¶°Ç / Ãâ½ÅÁö¿ª,È¥Àο©ºÎ,Àç»ê / Á÷°è Á¸ºñ¼Ó ¹× ÇüÁ¦ÀÚ¸ÅÀÇ ÇзÂ,Á÷¾÷,Àç»ê